Branko Cuglievan Selected Research

Branko Cuglievan Research Topics

Disease

17	Neoplasms (Cancer) 04/2024 - 01/2018
12	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 03/2024 - 09/2021
11	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2024 - 01/2021
5	Sarcoma (Soft Tissue Sarcoma) 01/2022 - 01/2018
4	Leukemia 02/2024 - 01/2022
4	Ewing Sarcoma (Sarcoma, Ewing) 07/2020 - 10/2018
3	Philadelphia Chromosome 02/2024 - 01/2023
3	Hodgkin Disease (Hodgkin's Disease) 11/2023 - 01/2022
2	Down Syndrome (Down's Syndrome) 03/2024 - 01/2023
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2023 - 02/2023
2	Hematologic Neoplasms (Hematological Malignancy) 01/2023 - 01/2021
2	Desmoplastic Small Round Cell Tumor 10/2018 - 01/2018
1	Lymphoma (Lymphomas) 03/2024
1	Hyperplasia 03/2024
1	Inflammation (Inflammations) 02/2024
1	Systemic Mastocytosis 01/2024
1	Monosomy 03/2023
1	monosomy Chromosome 7 03/2023
1	Residual Neoplasm 01/2023
1	Hematologic Diseases (Blood Diseases) 12/2022
1	Multiple Myeloma 11/2022
1	Prostatic Neoplasms (Prostate Cancer) 01/2022
1	Sinus Histiocytosis (Rosai-Dorfman Disease) 01/2022
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2021
1	Carcinoma (Carcinomatosis) 12/2021
1	Circulating Neoplastic Cells 12/2021
1	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 11/2021
1	Pancreatitis 09/2021
1	Sepsis (Septicemia) 01/2021
1	Acute Lung Injury 01/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2020

Drug/Important Bio-Agent (IBA)

4	blinatumomabIBA 03/2024 - 01/2023
4	venetoclaxIBA 11/2023 - 10/2021
3	Biomarkers (Surrogate Marker)IBA 02/2024 - 07/2020
2	Transcription Factors (Transcription Factor)IBA 05/2024 - 12/2021
2	Decitabine FDA Link 01/2024 - 10/2021
2	Inotuzumab OzogamicinIBA 12/2023 - 01/2023
2	Lysine (L-Lysine)FDA Link 01/2023 - 01/2021
2	MethyltransferasesIBA 01/2023 - 01/2021
2	Mitogen-Activated Protein KinasesIBA 01/2022 - 01/2021
1	Cytarabine (Cytosar-U)FDA LinkGeneric 03/2024
1	palbociclibIBA 03/2024
1	ChromatinIBA 03/2024
1	HomoharringtonineIBA 02/2024
1	Interferon-gamma (Interferon, gamma)IBA 02/2024
1	CytokinesIBA 02/2024
1	Tyrosine Kinase InhibitorsIBA 02/2024
1	tagraxofuspIBA 02/2024
1	avapritinibIBA 01/2024
1	Core Binding Factors (Core-Binding Factor)IBA 01/2024
1	Brentuximab VedotinIBA 11/2023
1	nuclear pore complex protein 98IBA 03/2023
1	Vincristine (Oncovin)FDA LinkGeneric 01/2023
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2023
1	Chimeric Antigen ReceptorsIBA 01/2023
1	Bispecific AntibodiesIBA 01/2023
1	Rituximab (Mabthera)FDA Link 01/2023
1	Interferon Regulatory FactorsIBA 11/2022
1	pembrolizumabIBA 01/2022
1	tisagenlecleucelIBA 01/2022
1	enzalutamideIBA 01/2022
1	AndrogensIBA 01/2022
1	EnzymesIBA 01/2022
1	Niacinamide (Nicotinamide)FDA LinkGeneric 01/2022
1	Androgen Receptors (Androgen Receptor)IBA 01/2022
1	TransferasesIBA 01/2022
1	Antisense OligonucleotidesIBA 01/2022
1	Cyclin D1IBA 01/2022
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2022
1	Apoptosis Regulatory ProteinsIBA 01/2022
1	gilteritinibIBA 12/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2021
1	antiarrhythmic peptide (AAP)IBA 09/2021
1	Asparaginase (Elspar)FDA Link 09/2021
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 07/2020
1	AntibodiesIBA 07/2020
1	caprolactoneIBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 12/2019
1	PlasticsIBA 12/2019
1	Immunoconjugates (Immunoconjugate)IBA 01/2019
1	PerforinIBA 01/2019
1	Antineoplastic Agents (Antineoplastics)IBA 01/2019
1	Monoclonal AntibodiesIBA 01/2019
1	EndoglinIBA 01/2019
1	Streptonigrin (Nigrin)IBA 01/2019
1	Cisplatin (Platino)FDA LinkGeneric 10/2018

Therapy/Procedure

17	Therapeutics 04/2024 - 01/2018
9	Drug Therapy (Chemotherapy) 03/2024 - 01/2018
4	Immunotherapy 03/2023 - 01/2021
2	Stem Cell Transplantation 12/2023 - 01/2022
2	Hematopoietic Stem Cell Transplantation 02/2023 - 01/2023
2	Critical Care (Surgical Intensive Care) 01/2022 - 01/2021
1	Autologous Transplantation 11/2023
1	Infant Equipment (Crib) 01/2023
1	Bioreactors (Bioreactor) 12/2021
1	Salvage Therapy 10/2021
1	Cell Transplantation 01/2021
1	Transplantation 01/2021
1	Combination Drug Therapy (Combination Chemotherapy) 12/2019